Decision-making in injustice: MAiD in Canada after Bill C-7

By Kayla Wiebe and Amy Mullin. In February, 2022, a Canadian citizen with a severe case of multiple chemical sensitivities (MCS) requested and subsequently received medical assistance in dying (MAiD). The decision to request MAiD was made after a two-year fight to access housing that would have made living with their condition tolerable. This kind of […]

Read More…

The dark side of psychedelics’ power

By Daniel Villiger. Last year, the German crime series Tatort, which belongs to the most watched television shows in Germany, Austria and Switzerland, aired an episode that takes place in the psychedelic underground. In his mansion, a spiritually-oriented psychiatrist hosts psychedelics sessions for his patients or, rather, his followers. Little surprisingly for a crime story, […]

Read More…

Re-thinking consent for treatment: clinical interests and the public interest

By Abeezar I. Sarela. In its recent guidance on consent, the General Medical Council (GMC) advises doctors to not provide treatment that ‘you (the doctor) don’t think would be in their (the patient’s) clinical interests’. It follows that doctors should only provide treatments that are in the patient’s clinical interests. But, what exactly is meant […]

Read More…

The furore around whole bodily gestational donation: a tale of misplaced anger?

By Anna Nelson. Prompted by a sensationalist headline in the Daily Mail, there has been a furore on social media around an article published last year by bioethicist Anna Smajdor in which she defends ‘Whole Bodily Gestational Donation’ (WBGD). Put simply WBGD means that, with prior consent, the bodies of women in a permanent vegetative […]

Read More…

David Bennett and the first porcine xenotransplantation

By Christopher Gyngell and Julian Savulescu. At 57, David Bennett was dying. He had a decades long history of heart disease. Prior treatments, including surgery, had proved ineffective. In November 2021, he was diagnosed with uncontrollable arrhythmia and was admitted to the University of Maryland Medical Centre. Despite the best efforts of clinicians, his condition […]

Read More…

Respecting autonomy in altered states: Navigating ethical quandaries in psychedelic therapy

By Hannah McLane, Courtney Hutchison, Daniel Wikler, Timothy Howell, & Emma Knighton. Research into psychedelic-assisted therapy has grown in the past ten years as non-profits, academic institutions, pharmaceutical companies, and even venture capitalists race to develop protocols for using MDMA, psilocybin, ketamine, and other psychedelic substances to treat mental illness. Already, dozens of ketamine clinics […]

Read More…